NCT06262633View on ClinicalTrials.gov

A Multi-centre Trial on Targeted Microwave Ablation (TMA) for Localized Prostate Cancer

NARecruitingINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

March 15, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

June 30, 2026

Conditions
Prostate Cancer
Interventions
DEVICE

Targeted Microwave Ablation (TMA) for localized prostate cancer using organ based tracking (OBT) navigation

Targeted microwave ablation (TMA) is a novel treatment developed for focal treatment of prostate cancer, and it is applied with precise navigation guidance under the organ-based tracking (OBT) mechanism.

Trial Locations (1)

Unknown

RECRUITING

Peter Ka-Fung CHIU, Shatin

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER